Portuguese pharmaceutical group FHC will use its acquisition of Activo Health to build its African footprint, beginning with a push into South Africa’s sterile injectables market, senior executives said yesterday. The privately held group bought Activo Health from JSE-listed Afrocentric. FHC owns Laboratórios Basi, a drugmaker based in Mortágua, Portugal, which reported turnover of about €543m (roughly R10bn) in 2025.…